ATAI
AtaiBeckley Inc.
Latest Form 4:Sale$496KbyHERSHBERG ROBERT (Director) · filed Jul 9, 2026
AtaiBeckley Inc. (ATAI) has 8 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 9, 2026.
The most active filer is Chief Medical Officer Craig Kevin James with 3 filings. Insiders have net sold $1.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Christian Angermayer
- Employees:99
- HQ:New York, NY, US
- IPO:2021-06-18
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.7M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$2.7B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
HERSHBERG ROBERTFirst in 7 months | Director | Sale | 100,000 | $496K | Jul 9 | SEC ↗ |
| Chief Medical Officer | Sale | 42,579 | $192K | Jun 29 | SEC ↗ | |
Kochendoerfer GerdFirst filing | Chief Operating Officer | Sale | 50,000 | $250K | Jun 29 | SEC ↗ |
| Chief Medical Officer | Sale | 42,579 | $213K | Apr 22 | SEC ↗ | |
Craig Kevin JamesFirst filing | Chief Medical Officer | Sale | 100,000 | $355K | Mar 24 | SEC ↗ |
Feilding-Mellen CosmoFirst filing | Director | Sale | 39,594 | $154K | Jan 6 | SEC ↗ |
Related companies
AtaiBeckley Inc. is in the Healthcare sector.